Life sciences stories
Enterprises can now turn plain-language requests into reviewable AI workflows, as Dataiku seeks to close the gap between prototypes and production.
The deal secures rare long-term UK AI capacity as demand for power-hungry inference computing outstrips available data centre infrastructure.
The deal should help the European consultancy expand as demand grows for data analytics and AI advice across financial services and retail.
Closer cooperation in artificial intelligence, health and defence follows Canada-Ireland talks as bilateral trade reached $6 billion last year.
Food and agriculture start-ups may see fresh capital as the firm targets software and biology plays after the sector's sharp funding pullback.
The tie-up aims to help regulated firms move generative AI from pilots into production, while training 50,000 TCS staff on Claude.
Many harmless prompts will now be diverted to Claude Opus 4.8 as Anthropic tightens safeguards around its newest general-use model.
Rising costs, security worries and data sovereignty are pushing more firms to run production AI inferencing in private cloud, a Broadcom survey shows.
Sensitive data can stay off the cloud as Custodia's Sentinel gives executives and researchers a local AI appliance for private document analysis.
It aims to help regulated industries connect AI agents to legacy systems without rebuilding core infrastructure, as demand for production rollouts grows.
Eligible research organisations can now access OpenAI's updated GPT-Rosalind model, as the company widens its life sciences rollout worldwide.
The recognition underlines rising demand for AI-enabled delivery centres as enterprises rethink offshore hubs for product and engineering work.
The move has cut month-end work and lifted invoice processing, while avoiding costly customisation and easing future upgrades.
Field sales teams will get AI-generated call plans in seconds as Sanofi expands Snowflake use across research, procurement and operations.
The new funding will help Triomics expand its AI platform across US cancer centres as it tackles labour-intensive oncology records and trial matching.
It aims to cut the manual work that leaves many connected-device networks exposed, by turning risk data into enforced policy automatically.
Greater multiplexing for researchers comes as the new system adds Deep Ultraviolet and Infrared lasers to support 60-colour panel development.
Tighter checks on synthetic DNA orders are gaining traction as AI makes it easier to turn digital designs into real-world biological risks.
Early users will get access to dedicated hardware and tools as Niobium tries to make encrypted cloud computing practical for sensitive workloads.
Foreign investors are helping drive Taiwan's stock market to record size as chip and AI shares account for more than four-fifths of value.